Аннотация
Проведен систематический обзор исследований, результаты которых опубликованы на английском языке с 2014 по 2021 г., с использованием баз данных PubMed, ScienceDirect, ProQuest, GoogleScholar, Scopus и Web of Science (примерно 75% всех источников). В обзор включены обзорные статьи, оригинальные ретроспективные и проспективные исследования. Представлены эпидемиологические сведения о SARS-CoV-2, его строении и патогенезе воздействия на клеткимишени. Описаны частота и распространенность сердечно-сосудистых заболеваний как коморбидных состояний у пациентов с COVID-19 в различных странах мира. Приведены данные о роли COVID-19 в патогенезе повреждения миокарда, развития аритмий, острого коронарного синдрома, сердечной недостаточности. К настоящему времени не описаны алгоритмы лечения пациентов с заболеваниями сердечно-сосудистой системы, перенесших COVID-19, что требует проведения дальнейших исследований.
Литература
- Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579: 270–3. DOI: 10.1038/s41586-020-2012-7
- Wu F., Zhao S., Yu B., Chen Y.M., Wang W., Song Z.G. et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579: 265–9. DOI: 10.1038/s41586-020-2008-3
- Lu R., Zhao X., Li J., Niu P., Yang B., Wu H. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395: 565–74. DOI: 10.1016/S0140-6736(20)30251-8
- Nishiga M., Wang D.W., Han Y., Lewis D.B., Wu J.C. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat. Rev. Cardiol. 2020; 17: 543–58. DOI: 10.1038/s41569-020-0413-9
- Report of coronavirus cases prevalence https://www. worldometers.info/coronavirus/country/russia/(дата доступа 15.07.2021).
- Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019; 17: 181–92. DOI: 10.1038/s41579-018-0118-9
- Bar-On Y.M., Flamholz A., Phillips R., Milo R. SARSCoV-2 (COVID-19) by the numbers. Elife. 2020; 9: e57309. DOI: 10.7554/eLife.57309
- Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367: 1260–3. DOI: 10.1126/science.abb2507
- Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotei. Cell. 2020; 181: 281–92. DOI: 10.1016/j.cell.2020.02.058
- Wan Y., Shang J., Graham R., Baric R.S., Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J. Virol. 2020; 94: e00127–20. DOI: 10.1128/JVI.00127-20
- Madjid M., Safavi-Naeini P., Solomon S.D., Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020; 5 (7): 831–40. DOI: 10.1001/jamacardio.2020.1286
- Clerkin K.J., Fried J.A., Raikhelkar J., Sayer G., Griffin J.M., Masoumi A. et al. COVID-19 and cardiovascular disease. Circulation. 2020; 141 (20): 1648–55. DOI: 10.1161/CIRCULATIONAHA.120.046941
- Driggin E., Madhavan M.V., Bikdeli B., Chuich T., Laracy J., Biondi-Zoccai G. et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J. Am. Coll. Cardiol. 2020; 75: 2352–71. DOI: 10.1016/j.jacc.2020. 03.031
- Zheng Y.Y., Ma Y.T., Zhang J.Y., Xie X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 2020; 17: 259–60. DOI: 10.1038/s41569-020-0360-5
- Jiang F., Yang J., Zhang Y., Dong M., Wang S., Zhang Q. et al. Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets. Nat. Rev. Cardiol. 2014; 11: 413–26. DOI: 10.1038/nrcardio.2014.59
- GTEx Portal (ACE2). Gene expression for ACE2. Available at: https://www.gtexportal.org/home/gene/ACE2 (2020) (дата доступа 15.07.2021).
- Chen L., Li X., Chen M., Feng Y., Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc. Res. 2020; 116: 1097–100. DOI: 10.1093/cvr/cvaa078
- Litviňuková M., López C.T., Maatz H., Reichart D., Worth C.L., Lindberg E.L. et al. Cells and gene expression programs in the adult human heart. 2020; 588: 466–72. DOI: 10.1101/2020.04.03.024075
- Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497–506. DOI: 10.1016/S0140-6736(20)30183-5
- Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323 (11): 1061–9. DOI: 10.1001/jama.2020.1585
- Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395: 1054–62. DOI: 10.1016/S0140-6736(20)30566-3
- Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020; 382: 1708–20. DOI: 10.1056/NEJMoa2002032
- Grasselli G., Zangrillo A., Zanella A., Antonelli M., Cabrini L., Castelli A. et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020; 323 (16): 1574–81. DOI: 10.1001/jama.2020.5394
- Goyal P., Choi J.J., Pinheiro L.C., Schenck E.J., Chen R., Jabri A. et al. Clinical characteristics of COVID-19 in 35 Сердечно-сосудистые заболевания. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2022; 23 (1) DOI: 10.24022/1810-0694-2022-23-1-30-35 Обзоры New York City. N. Engl. J. Med. 2020; 382: 2372–4. DOI: 10.1056/NEJMc2010419
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323 (13): 1239–41. DOI: 10.1001/jama.2020.2648
- Arentz M., Yim E., Klaff L., Lokhandwala S., Riedo F.X., Chong M. et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington state. JAMA. 2020; 323 (16): 1612–4. DOI: 10.1001/jama.2020.4326
- Bhatraju P.K., Ghassemieh B.J., Nichols M., Kim R., Jerome K.R., Nalla A.K. et al. COVID-19 in critically ill patients in the Seattle region – case series. N. Engl. J. Med. 2020; 382: 2012–22. DOI: 10.1056/NEJMoa 2004500
- Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323 (20): 2051–9. DOI: 10.1001/jama. 2020.6775
- Stefanini G.G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M. et al. ST-elevation myocardial infarction in patients with COVID-19: clinical and angiographic outcomes. Circulation. 2020; 141: 2113–6. DOI: 10.1161/CIRCULATIONAHA.120. 047525
- Deng Q., Hu B., Zhang Y., Wang H., Zhou X., Hu W. et al. Suspected myocardial injury in patients with COVID-19: evidence from front-line clinical observation in Wuhan, China. Int. J. Cardiol. 2020; 311: 116–21. DOI: 10.1016/j.ijcard.2020.03.087
- Anupama B.K., Chaudhuri D.A. Review of acute myocardial injury in coronavirus disease 2019. Cureus. 2020; 12 (6): e8426. DOI: 10.7759/cureus.8426
- Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F. et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5 (7): 802–10. DOI: 10.1001/jamacardio. 2020.0950
- Guo T., Fan Y., Chen M., Wu X., Zhang L., He T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5 (7): 811–18. DOI: 10.1001/jamacardio. 2020.1017
- Inciardi R.M., Lupi L., Zaccone G., Italia L., Raffo M., Tomasoni D. et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5 (7): 819–24. DOI: 10.1001/jamacardio. 2020.1096
- Hu H., Ma F., Wei X., Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur. Heart J. 2020; 42 (2): 206. DOI: 10.1093/eurheartj/ehaa190
- Fox S.E., Akmatbekov A., Harbert J.L., Li G., Quincy Brown J., Vander Heide R.S. Pulmonary and cardiac pathology in Covid-19. The first autopsy series from New Orleans. Lancet Respir. Med. 2020; 10: 2213–600. DOI: 10.1016/S2213-2600(20)30243-5
- Perez-Bermejo J.A., Kang S., Rockwood S.J., Simoneau C.R., Joy D.A., Silva A.C. et al. SARS-CoV-2 infection of human iPSC-derived cardiac cells predicts novel cytopathic features in hearts of COVID-19 patients. Sci. Transl. Med. 2021; 13: 7872. DOI: 10.1126/scitranslmed.abf7872
- Kwong J.C., Schwartz K.L., Campitelli M.A., Chung H., Crowcroft N.S., Karnauchow T. et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N. Engl. J. Med. 2018; 378: 345–53. DOI: 10.1056/NEJMoa1702090
- Bangalore S., Sharma A., Slotwiner A., Yatskar L., Harari R., Shah B. et al. ST-segment elevation in patients with COVID-19 – a case series. N. Engl. J. Med. 2020; 382: 2478–80. DOI: 10.1056/NEJMc2009020
- Libby P., Tabas I., Fredman G., Fisher E.A. Inflammation and its resolution as determinants of acute coronary syndromes. Circ. Res. 2014; 114: 1867–79. DOI: 10.1161/CIRCRESAHA.114.302699
- Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S. et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395: 1417–8. DOI: 10.1016/S0140-6736(20)30937-5
- De Filippo O., D’Ascenzo F., Angelini F., Bocchino P.P., Conrotto F., Saglietto A. et al. Reduced rate of hospital admissions for ACS during COVID-19 outbreak in Northern Italy. N. Engl. J. Med. 2020; 383: 88–9. DOI: 10.1056/NEJMc2009166
- Rodriguez-Gonzalez M., Castellano-Martinez A., Cascales-Poyatos H.M., Perez Reviriego A.A. Impact of the COVID-19 pandemic on interventional cardiology activity in Spain. Rec. Interv. Cardiol. Engl. Ed. 2020; 16: 247–50. DOI: 10.12998/wjcc.v8.i21.5250
- De Rosa S., Spaccarotella C., Basso C., Calabrò M.P., Curcio A., Filardi P.P. et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur. Heart J. 2020; 41: 2083–8. DOI: 10.1093/eurheartj/ehaa409
- Chen T., Wu D., Chen H., Yan W., Yang D., Chen G. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020; 368: 1091. DOI: 10.1136/bmj.m1091
- Mehra M.R., Ruschitzka F. COVID-19 illness and heart failure: a missing link? JACC Heart Fail. 2020; 8: 512–4. DOI: 10.1016/j.jchf.2020.03.004
- Deng Y., Liu W., Liu K., Fang Y.Y., Shang J., Zhou L. et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei province. Chin. Med. J. 2020; 133: 1025–31. DOI: 10.1097/CM9.0000000000000824
- Lakkireddy D.R., Chung M.K., Gopinathannair R., Patton K.K., Gluckman T.J., Turagam M. et al. Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 task force; electrophysiology section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Circulation. 2020; 141: 823–31. DOI: 10.1016/j.hrthm.2020.03.028
- Sanders J.M., Monogue M.L., Jodlowski T.Z., Cutrell J.B. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020; 323 (18): 1822–36. DOI: 10.1001/jama.2020.6019
Об авторах
- Бокерия Лео Антонович, академик РАН и РАМН, президент; ORCID
- Джобава Есма Роландовна, канд. мед. наук, врач-кардиолог; ORCID
- Пацоева Иман Масудовна, аспирант, кардиолог; ORCID
